LifeStance Health will present at the UBS Global Healthcare Conference on November 10, 2025, at 4:15 p.m. ET.
Quiver AI Summary
LifeStance Health Group, Inc. announced that CEO Dave Bourdon will present at the UBS Global Healthcare Conference on November 10, 2025, at 4:15 p.m. Eastern time, in Palm Beach Gardens, FL. The presentation will be moderated by Kevin Caliendo and will be available for live webcast on the LifeStance Health Investor Relations website, with a replay accessible afterward. LifeStance, founded in 2017, is a leading provider of outpatient mental health care, offering services for children, adolescents, and adults across 33 states through over 550 centers. The company's mission focuses on improving access to personalized mental health care, employing around 7,700 professionals in the field.
Potential Positives
- LifeStance Health Group's participation in the UBS Global Healthcare Conference highlights its prominence in the mental health care sector.
- The live webcast of the presentation increases transparency and accessibility for investors and stakeholders.
- The company's growth is underscored by its employment of approximately 7,700 mental health professionals and operation in over 550 centers across 33 states.
Potential Negatives
- None
FAQ
When is LifeStance Health presenting at the UBS Global Healthcare Conference?
LifeStance Health will present on Monday, November 10, 2025, at 4:15 p.m. Eastern time.
Who is presenting for LifeStance Health at the conference?
Dave Bourdon, the CEO of LifeStance Health, will present at the conference.
Where can I watch the LifeStance Health presentation?
The presentation will be webcast live on the Events and Presentations section of the LifeStance Health Investor Relations website.
Will there be a replay available for the LifeStance Health presentation?
Yes, a replay of the webcast will be available on the LifeStance Health Investor Relations website after the event.
What services does LifeStance Health provide?
LifeStance Health provides virtual and in-person outpatient mental health care for children, adolescents, and adults.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$LFST Insider Trading Activity
$LFST insiders have traded $LFST stock on the open market 10 times in the past 6 months. Of those trades, 5 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $LFST stock by insiders over the last 6 months:
- PARTNERS L P SUMMIT sold 8,407,643 shares for an estimated $42,626,750
- DARREN M. BLACK sold 8,407,643 shares for an estimated $42,626,750
- PARTNERS I GP, LLC SILVERSMITH sold 3,592,357 shares for an estimated $18,213,249
- KENNETH A BURDICK has made 5 purchases buying 114,181 shares for an estimated $498,293 and 0 sales.
- UJJWAL RAMTEKKAR (Chief Medical Officer) has made 0 purchases and 2 sales selling 25,519 shares for an estimated $144,253.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$LFST Hedge Fund Activity
We have seen 121 institutional investors add shares of $LFST stock to their portfolio, and 80 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC removed 4,723,411 shares (-13.6%) from their portfolio in Q2 2025, for an estimated $24,420,034
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 4,410,685 shares (+inf%) to their portfolio in Q2 2025, for an estimated $22,803,241
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 2,338,219 shares (+379.8%) to their portfolio in Q2 2025, for an estimated $12,088,592
- DIMENSIONAL FUND ADVISORS LP added 1,746,703 shares (+36.2%) to their portfolio in Q2 2025, for an estimated $9,030,454
- BANK OF AMERICA CORP /DE/ added 1,302,140 shares (+280.1%) to their portfolio in Q2 2025, for an estimated $6,732,063
- GOLDMAN SACHS GROUP INC removed 1,182,251 shares (-23.6%) from their portfolio in Q2 2025, for an estimated $6,112,237
- QUBE RESEARCH & TECHNOLOGIES LTD added 1,166,045 shares (+90.5%) to their portfolio in Q2 2025, for an estimated $6,028,452
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$LFST Analyst Ratings
Wall Street analysts have issued reports on $LFST in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- UBS issued a "Buy" rating on 08/08/2025
To track analyst ratings and price targets for $LFST, check out Quiver Quantitative's $LFST forecast page.
Full Release
SCOTTSDALE, Ariz., Oct. 28, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental health care, today announced that management will present at the upcoming UBS Global Healthcare Conference, which will be hosted in Palm Beach Gardens, FL.
Details of the presentation are as follows:
Presenter: Dave Bourdon, CEO
Date: Monday, November 10, 2025
Time: 4:15 p.m. (Eastern time)
Moderated by: Kevin Caliendo
The presentation will be webcast live and will be available on the Events and Presentations section of the LifeStance Health Investor Relations website ( https://investor.lifestance.com ).
A replay of the webcast will be available after the conclusion of the event and can be accessed on the LifeStance Health Investor Relations website.
About LifeStance Health
Founded in 2017,
LifeStance
(NASDAQ: LFST) is reimagining mental health. We are one of the nation’s largest providers of virtual and in-person outpatient mental health care for children, adolescents and adults experiencing a variety of mental health conditions. Our mission is to help people lead healthier, more fulfilling lives by improving access to trusted, affordable and personalized mental health care. LifeStance and its supported practices employ approximately 7,700 psychiatrists, advanced practice nurses, psychologists and therapists and operate across 33 states and more than 550 centers. To learn more, please visit
www.LifeStance.com
.
Investor Contact:
Monica Prokocki
VP of Finance and Investor Relations
[email protected]
Media Contact:
Brooke Matthews
Sr. Director of Communications
[email protected]
